Loading clinical trials...
Loading clinical trials...
COVID 19 Antibody Seroprevalence Amongst Healthcare Workers in Johns Hopkins Aramco Healthcare
Conditions
Interventions
Serology Test
Locations
1
Saudi Arabia
Johns Hopkins Aramco Healthcare
Dhahran, Eastern Province, Saudi Arabia
Start Date
July 19, 2020
Primary Completion Date
January 15, 2021
Completion Date
June 15, 2021
Last Updated
July 29, 2020
NCT07278388
NCT07123727
NCT07013903
NCT05040659
NCT06391489
NCT06992401
Lead Sponsor
Johns Hopkins Aramco Healthcare
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions